Bleeding Risk Assessment System for Antithrombotic Therapy of ACS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

6379 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-04

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Antithrombotic therapy is the cornerstone of the management of patients with acute coronary syndrome (ACS), which result in lower risk of mortality and ischemic events. But, accompanied side effect of bleeding always causing worsens outcomes. Tools to evaluate risk/benefit ratio is useful in daily practice. The in-used scores, such as CRUSADE, are derived from retrospective studies, without all types of ACS and without long-term prediction. This project aims to establish a database of anti-thrombosis treatment and bleeding in five large centers in Beijing through the observational registry of ACS. With the database, establish a bleeding risk assessment system that can be used for all ACS patients and can predict the full course of antithrombotic treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Registry of Bleeding Risk in Real World Chinese Acute Coronary Syndrome Patients-II

NCT03402711

Acute Coronary Syndrome Percutaneous Coronary Intervention Bleeding

UNKNOWN

Evaluation of C13 Breath Test for Upper Gastrointestinal Bleeding in Patients Who Need Double Antiplatelet After PCI

NCT04012801

Acute Myocardial Infarction

UNKNOWN

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

NCT04184583

Drug Therapy Acute Coronary Syndrome

NOT_YET_RECRUITING

Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow Ratio

NCT07110298

Coronary Arterial Disease (CAD)

COMPLETED

Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease

NCT05015270

Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age18-85 years old
2. Diagnosed ACS
3. Signed informed consent form

Exclusion Criteria

1. Any active bleeding
2. Not tolerate to anti-thrombotic drugs
3. A planned elective surgical procedure that would necessitate an interruption in treatment with antiplatelet therapy in the next 6 months after enrollment
4. Patients who died of non-bleeding causes within 24 hours after admission
5. Noncardiac coexisting conditions that could limit life expectancy to less than 1 year
6. Pregnancy or lactation

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No